www.fdanews.com/articles/71973-mdi-plans-development-of-fda-approved-e2-collector
MDI Plans Development of FDA-Approved e2 Collector
May 5, 2005
Molecular Diagnostics (MDI) announced plans for the final premanufacturing development of the company's e2 Collector, prior to beginning manufacturing later this year. MDI's FDA-approved e2 Collector is the first significant improvement in the collection of cell samples for the cervical cancer PAP test.